Cancer/testis antigens and gametogenesis: A review and "brain-storming" session

Cancer Cell International

Volumn 5, Issue , 2005, Pages

  Kalejs, Martins ^a   Erenpreisa, Jekaterina ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

Author keywords

CTA genes; Gametogenesis; Polyploidy

Indexed keywords

CANCER TESTIS ANTIGEN; MAGPHININ; PROTEIN BORIS; PROTEIN MAGE A; PROTEIN MAGE C1; PROTEIN NY ESO 1; PROTEIN OY TES 1; PROTEIN PLU 1; PROTEIN SCP; PROTEIN SPANX; PROTEIN TPTE; PROTEIN TSP 50; SYNOVIAL SARCOMA X BREAKPOINT PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; CANCER CELL; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE; CELL SURVIVAL; GAMETOGENESIS; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC STABILITY; GERM CELL; INFORMATION PROCESSING; LIFE CYCLE; MEIOSIS; MUTAGENESIS; NONHUMAN; ONTOGENY; PHYLOGENY; PLOIDY; REVIEW; SEX DIFFERENTIATION; TESTIS CANCER; TUMOR IMMUNOLOGY;

EID: 18144429106     PISSN: 14752867     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2867-5-4     Document Type: Review

References (96)

1. Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS: Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation 1963, 1:174-180.
2. Gold P, Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965, 122:467-481.
3. van der BP, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den EB, Knuth A, Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991, 254:1643-1647.
4. Traversari C, van der BP, Van den EB, Hainaut P, Lemoine C, Ohta N, Old L, Boon T: Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992, 35:145-152.
5. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A 1995, 92:11810-11813.
6. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A 1997, 94:1914-1918.
7. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M: Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci U S A 1998, 95:5211-5216.
8. Old LJ: Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun 2001, 1:1.
9. Scanlan MJ, Simpson AJ, Old LJ: The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004, 4:1.
10. Yuasa T, Okamoto K, Kawakami T, Mishina M, Ogawa O, Okada Y: Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. J Urol 2001, 165:1790-1794.
11. Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ: Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001, 92:856-860.
12. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der BP, Lethe B, Lurquin C, .: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994, 40:360-369.
13. Zendman AJ, Van Kraats AA, Weidle UH, Ruiter DJ, Van Muijen GN: The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma. Int J Cancer 2002, 99:361-369.
14. Zendman AJ, Ruiter DJ, Van Muijen GN: Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol 2003, 194:272-288.
15. Shichijo S, Yamada A, Sagawa K, Iwamoto O, Sakata M, Nagai K, Itoh K: Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2′-deoxycytidine. Jpn J Cancer Res 1996, 87:751-756.
16. De Smet C, Lurquin C, Lethe B, Martelange V, Boon T: DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999, 19:7327-7335.
17. Klenova EM, Morse HCIII, Ohlsson R, Lobanenkov VV: The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin Cancer Biol 2002, 12: 399-414.
18. Miller AP, Willard HF: Chromosomal basis of X chromosome inactivation: identification of a multigene domain in Xp11.21-p11.22 that escapes X inactivation. Proc Natl Acad Sci U S A 1998, 95:8709-8714.
19. Mintz B, Illmensee K: Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 1975, 72:3585-3589.
20. Park JH, Lee SW: Hypertonicity induction of melanoma antigen, a tumor-associated antigen. Mol Cells 2002, 13:288-295.
21. Coulie PG, Van den Eynde BJ, van der BP, Van Pel A, Boon T: Antigens recognized by T-lymphocytes on human tumours. Biochem Soc Trans 1997, 25:544-548.
22. Dalerba P, Ricci A, Russo V, Rigatti D, Nicotra MR, Mottolese M, Bordignon C, Natali PG, Traversari C: High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies. Int J Cancer 1998, 77:200-204.
23. Sahin U, Tureci O, Chen YT, Seitz G, Villena-Heinsen C, Old LJ, Pfreundschuh M: Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer 1998, 78:387-389.
24. Zendman AJ, de Wit NJ, van Kraats AA, Weidle UH, Ruiter DJ, van Muijen GN: Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma. Melanoma Res 2001, 11: 451-459.
25. Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, Aoe M, Nakamura S, Higashi T, Hiraki A, Wada H, Kumon H, Old LJ, Nakayama E: Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci U S A 2001, 98:3282-3287.
26. Romanienko PJ, Camerini-Otero RD: Cloning, characterization, and localization of mouse and human SPO11. Genomics 1999, 61:156-169.
27. Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA, Cui H, Niemitz EL, Rasko JE, Docquier FM, Kistler M, Breen JJ, Zhuang Z, Quitschke WW, Renkawitz R, Klenova EM, Feinberg AP, Ohlsson R, Morse HCIII, Lobanenkov VV: BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci U S A 2002, 99:6806-6811.
28. Shan J, Yuan L, Xiao Q, Chiorazzi N, Budman D, Teichberg S, Xu HP: TSP50, a possible protease in human testes, is activated in breast cancer epithelial cells. Cancer Res 2002, 62: 290-294.
29. Scanlan MJ, Gordon CM, Williamson B, Lee SY, Chen YT, Stockert E, Jungbluth A, Ritter G, Jager D, Jager E, Knuth A, Old LJ: Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 2002, 98:485-492.
30. Gupta SK, Alves K, Palladino LO, Mark GE, Hollis GF: Molecular cloning of the human fertilin beta subunit. Biochem Biophys Res Commun 1996, 224:318-326.
31. Koslowski M, Tureci O, Bell C, Krause P, Lehr HA, Brunner J, Seitz G, Nestle FO, Huber C, Sahin U: Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res 2002, 62:6750-6755.
32. Kuwako K, Taniura H, Yoshikawa K: Necdin-related MAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor. J Biol Chem 2004, 279: 1703-1712.
33. de Bruijn DR, dos Santos NR, Kater-Baats E, Thijssen J, van den BL, Stap J, Balemans M, Schepens M, Merkx G, van Kessel AG: The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP. Genes Chromosomes Cancer 2002, 34:285-298.
34. Yang K, Lui WO, Xie Y, Zhang A, Skytting B, Mandahl N, Larsson C, Larsson O: Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. Oncogene 2002, 21:4181-4190.
35. Storlazzi CT, Mertens F, Mandahl N, Gisselsson D, Isaksson M, Gustafson P, Domanski HA, Panagopoulos I: A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. Genes Chromosomes Cancer 2003, 37:195-200.
36. dos Santos NR, de Bruijn DR, Balemans M, Janssen B, Gartner F, Lopes JM, de Leeuw B, Geurts K: Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. Hum Mol Genet 1997, 6:1549-1558.
37. dos Santos NR, de Bruijn DR, Kater-Baats E, Otte AP, van Kessel AG: Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization. Exp Cell Res 2000, 256:192-202.
38. Tureci O, Sahin U, Koslowski M, Buss B, Bell C, Ballweber P, Zwick C, Eberle T, Zuber M, Villena-Heinsen C, Seitz G, Pfreundschuh M: A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing. Oncogene 2002, 21: 3879-3888.
39. Pivot-Pajot C, Caron C, Govin J, Vion A, Rousseaux S, Khochbin S: Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. Mol Cell Biol 2003, 23:5354-5365.
40. Madsen B, Tarsounas M, Burchell JM, Hall D, Poulsom R, Taylor-Papadimitriou J: PLU-1, a transcriptional repressor and putative testis-cancer antigen, has a specific expression and localisation pattern during meiosis. Chromosoma 2003, 112:124-132.
41. Westbrook VA, Schoppee PD, Diekman AB, Klotz KL, Allietta M, Hogan KT, Slingluff CL, Patterson JW, Frierson HF, Irvin WPJ, Flickinger CJ, Coppola MA, Herr JC: Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell lines. Clin Cancer Res 2004, 10:101-112.
42. Westbrook VA, Diekman AB, Klotz KL, Khole VV, Kap-Herr C, Golden WL, Eddy RL, Shows TB, Stoler MH, Lee CY, Flickinger CJ, Herr JC: Spermatid-specific expression of the novel X-linked gene product SPAN-X localized to the nucleus of human spermatozoa. Biol Reprod 2000, 63:469-481.
43. Ultrastructural pathology of cell and matrix. Volume 1. 3rd edition. Edited by: Ghadially FN. London, Butterworths; 2004.
44. Erenpreisa J, Ivanov A, Cragg M, Selivanova G, Illidge T: Nuclear envelope-limited chromatin sheets are part of mitotic death. Histochem Cell Biol 2002, 117:243-255.
45. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ: cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 1996, 271:29265-29270.
46. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl AD, Gearing DP, Sokol SY, McCarthy SA: Functional and structural diversity of the human Dickkopf gene family. Gene 1999, 238:301-313.
47. Karim R, Tse G, Putti T, Scolyer R, Lee S: The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004, 36:120-128.
48. Bergstein I, Eisenberg LM, Bhalerao J, Jenkins NA, Copeland NG, Osborne MP, Bowcock AM, Brown AM: Isolation of two novel WNT genes, WNT14 and WNT15, one of which (WNT15) is closely linked to WNT3 on human chromosome 17q21. Genomics 1997, 46:450-458.
49. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JRIII, Nusse R: Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003, 423:448-452.
50. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL: A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003, 423:409-414.
51. Polakis P: Wnt signaling and cancer. Genes Dev 2000, 14:1837-1851.
52. Taipale J, Beachy PA: The Hedgehog and Wnt signalling pathways in cancer. Nature 2001, 411:349-354.
53. Satie AP, Rajpert-De Meyts E, Spagnoli GC, Henno S, Olivo L, Jacobsen GK, Rioux-Leclercq N, Jegou B, Samson M: The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab Invest 2002, 82:775-780.
54. Cho B, Lim Y, Lee DY, Park SY, Lee H, Kim WH, Yang H, Bang YJ, Jeoung DI: Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem Biophys Res Commun 2002, 292:715-726.
55. Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T: Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res 2000, 60:3848-3855.
56. O'Bryan MK, Sebire K, Meinhardt A, Edgar K, Keah HH, Hearn MT, De Kretser DM: Tpx-1 is a component of the outer dense fibers and acrosome of rat spermatozoa. Mol Reprod Dev 2001, 58: 116-125.
57. Stevanovic S: Identification of tumour-associated T-cell epitopes for vaccine development. Nat Rev Cancer 2002, 2:514-520.
58. Atanackovic D, Altorki NK, Stockert E, Williamson B, Jungbluth AA, Ritter E, Santiago D, Ferrara CA, Matsuo M, Selvakumar A, Dupont B, Chen YT, Hoffman EW, Ritter G, Old LJ, Gnjatic S: Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients. J Immunol 2004, 172:3289-3296.
59. Ehlken H, Schadendorf D, Eichmuller S: Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells. Int J Cancer 2004, 108:307-313.
60. Wang RF, Rosenberg SA: Human tumor antigens recognized by T lymphocytes: implications for cancer therapy. J Leukoc Biol 1996, 60:296-309.
61. Sahin U, Tureci O, Pfreundschuh M: Serological identification of human tumor antigens. Curr Opin Immunol 1997, 9:709-716.
62. Tureci O, Sahin U, Pfreundschuh M: Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today 1997, 3:342-349.
63. Hubank M, Schatz DG: Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 1994, 22:5640-5648.
64. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971.
65. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD: Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A 1996, 93:6025-6030.
66. McCurdy DK, Tai LQ, Nguyen J, Wang Z, Yang HM, Udar N, Naiem F, Concannon P, Gatti RA: MAGE Xp-2: a member of the MAGE gene family isolated from an expression library using systemic lupus erythematosus sera. Mol Genet Metab 1998, 63:3-13.
67. Lea IA, Adoyo P, O'Rand MG: Autoimmunogenicity of the human sperm protein Sp17 in vasectomized men and identification of linear B cell epitopes. Fertil Steril 1997, 67:355-361.
68. Bart J, Groen HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaalburg W, Sleijfer DT, de Vries EG: An oncological view on the blood-testis barrier. Lancet Oncol 2002, 3:357-363.
69. Fiszer D, Kurpisz M: Major histocompatibility complex expression on human, male germ cells: a review. Am J Reprod Immunol 1998, 40:172-176.
70. Erenpreiss JO: Current concepts of malignant growth. Part A. From a Normal Cell to Cancer. Riga, Zvaigzne publishers; 1993.
71. Kufe D, Pollock R, Weicheselbaum R, Bast R, Gansler T, Holland J, Frie E: Cancer Medicine 6th edition. Hamilton (Canada), BC. Decker Inc.; 2003.
72. Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, Borg A, Isola JJ: Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000, 6:1833-1839.
73. Hidaka S, Yasutake T, Takeshita H, Kondo M, Tsuji T, Nanashima A, Sawai T, Yamaguchi H, Nakagoe T, Ayabe H, Tagawa Y: Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 2000, 6: 2712-2717.
74. Raderschall E, Stout K, Freier S, Suckow V, Schweiger S, Haaf T: Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res 2002, 62:219-225.
75. Erenpreis YG: The function of nucleic acids in the differentiation of neoplastic processes New York, Daniel Davey a. Co; 1964.
76. Erenpreiss JG: Gametogenesis as a molecular model of cancerogenesis: A current view of the embryological theory of cancer. Proc Latv Acad Sci Part B 1992, 3:55-63.
77. Vinnitsky VB: Oncogerminal hypothesis of tumour growth. perimental Oncology 1989, 11:59-66.
78. Cleveland LR: The origin and evolution of meiosis. Science 1947, 105:287-289.
79. Kondrashov AS: The asexual ploidy cycle and the origin of sex. Nature 1994, 370:213-216.
80. Raikov IB: The Protozoan Nucleus. Morphology and Evolution Wien-New York, Springer Verlag; 1982.
81. Raikov IB: Meiosis in protists: recent advances and persisting problems. r J Protistol 1995, 31:1-7.
82. Nagl W: Endopolyploidy and Polyteny in Differentiation and Evolution Amsterdam-New York-Oxford, North-Holland Pub.,; 1978.
83. Kondrashov AS: Evolutionary genetics of life cycles. nu Rev Ecol Syst, 1997:391-435.
84. Zybina EV, Zybina TG: Polytene chromosomes in mammalian cells. Int Rev Cytol 1996, 165:53-119.
85. Zybina TG, Zybina EV, Kiknadze II, Zhelezova AI: Polyploidization in the trophoblast and uterine glandular epithelium of the endotheliochorial placenta of silver fox (Vulpes fulvus Desm.), as revealed by the DNA content. Placenta 2001, 22:490-498.
86. Ivanov A, Cragg MS, Erenpreisa J, Emzinsh D, Lukman H, Illidge TM: Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks. J Cell Sci 2003, 116:4095-4106.
87. Buglioni S, D'Agnano I, Vasselli S, Perrone DR, D'Angelo C, Brenna A, Benevolo M, Cosimelli M, Zupi G, Mottolese M: p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy. Am J Clin Pathol 2001, 116:360-368.
88. Baroja A, de la HC, Alvarez A, Ispizua A, Bilbao J, de Gandarias JM: Genesis and evolution of high-ploidy tumour cells evaluated by means of the proliferation markers p34(cdc2), cyclin B1, PCNA and 3[H]-thymidine. Cell Prolif 1996, 29:89-100.
89. Baroja A, de la HC, Alvarez A, Vielba R, Sarrat R, Arechaga J, de Gandarias JM: Polyploidization and exit from cell cycle as mechanisms of cultured melanoma cell resistance to methotrexate. Life Sci 1998, 62:2275-2282.
90. Erenpreisa JA, Cragg MS, Fringes B, Sharakhov I, Illidge TM: Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell line. Cell Biol Int 2000, 24: 635-648.
91. Illidge TM, Cragg MS, Fringes B, Olive P, Erenpreisa JA: Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage. Cell Biol Int 2000, 24:621-633.
92. Saburi S, Nadano D, Akama TO, Hirama K, Yamanouchi K, Naito K, Tojo H, Tachi C, Fukuda MN: The trophinin gene encodes a novel group of MAGE proteins, magphinins, and regulates cell proliferation during gametogenesis in the mouse. J Biol Chem 2001, 276:49378-49389.
93. Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan K, Chen YT, Spagnoli GC, Old LJ: Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 2000, 85:460-465.
94. Jungbluth AA, Chen YT, Busam KJ, Coplan K, Kolb D, Iversen K, Williamson B, Van Landeghem FK, Stockert E, Old LJ: CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues. Int J Cancer 2002, 99:839-845.
95. Meuwissen RL, Offenberg HH, Dietrich AJ, Riesewijk A, van Iersel M, Heyting C: A coiled-coil related protein specific for synapsed regions of meiotic prophase chromosomes. EMBO J 1992, 11:5091-5100.
96. Tapparel C, Reymond A, Girardet C, Guillou L, Lyle R, Lamon C, Hutter P, Antonarakis SE: The TPTE gene family: cellular expression, subcellular localization and alternative splicing. Gene 2003, 323:189-199.